Company
Ipsen
Learn about Ipsen, a global pharma company that aims to prolong patients’ lives, improve health outcomes and create a positive impact for patients and society.
Ipsen is a publicly traded company operating in the activities of head offices and pharmaceutical industry sectors, based in France. It trades on the OTC Markets Group under the ticker IPSEY. Leadership tracked by CEOInsider includes David Loew (CEO).
Leadership
Current
Recent developments
AI summary of recent coverageRecent coverage has focused on Ipsen's strategic positioning and capital deployment, including consideration of U.S. manufacturing investments and the company's substantial financial capacity to pursue acquisitions. News reports have highlighted Ipsen's robust financial performance across its business segments and its stated readiness to compete in rare diseases and pursue deal-making opportunities with approximately €2 billion in available resources.
Summarized from the headlines in the sidebar; see each source for the full story.